Literature DB >> 22963480

Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection.

Colin J Davidson1, Emily Zeringer, Kristen J Champion, Marie-Pierre Gauthier, Fawn Wang, Jerry Boonyaratanakornkit, Julie R Jones, Edgar Schreiber.   

Abstract

Fluorescent dye terminator Sanger sequencing (FTSS), with detection by automated capillary electrophoresis (CE), has long been regarded as the gold standard for variant detection. However, software analysis and base-calling algorithms used to detect mutations were largely optimized for resequencing applications in which different alleles were expected as heterozygous mixtures of 50%. Increasingly, the requirements for variant detection are an analytic sensitivity for minor alleles of <20%, in particular, when assessing the mutational status of heterogeneous tumor samples. Here, we describe a simple modification to the FTSS workflow that improves the limit of detection of cell-line gDNA mixtures from 50%-20% to 5% for G>A transitions and from 50%-5% to 5% for G>C and G>T transversions. In addition, we use two different sample types to compare the limit of detection of sequence variants in codons 12 and 13 of the KRAS gene between Sanger sequencing and other methodologies including shifted termination assay (STA) detection, single-base extension (SBE), pyrosequencing (PS), high- resolution melt (HRM), and real-time PCR (qPCR).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963480     DOI: 10.2144/000113913

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  18 in total

Review 1.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Authors:  Armand de Gramont; Sarah Watson; Lee M Ellis; Jordi Rodón; Josep Tabernero; Aimery de Gramont; Stanley R Hamilton
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

2.  Novel hereditary spherocytosis-associated splice site mutation in the ANK1 gene caused by parental gonosomal mosaicism.

Authors:  Xiong Wang; Na Shen; Ming Huang; Yanjun Lu; Qun Hu
Journal:  Haematologica       Date:  2018-02-15       Impact factor: 9.941

3.  Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers.

Authors:  Chonlaphat Sukasem; Chalirmporn Atasilp; Pichai Chansriwong; Montri Chamnanphon; Apichaya Puangpetch; Ekapob Sirachainan
Journal:  J Clin Lab Anal       Date:  2014-12-26       Impact factor: 2.352

4.  Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-Specific 16S rRNA gene sequences.

Authors:  Marion Walcher; Rhonda Skvoretz; Megan Montgomery-Fullerton; Vivian Jonas; Steve Brentano
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

5.  Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.

Authors:  Bill H Diplas; Heng Liu; Rui Yang; Landon J Hansen; Alexis L Zachem; Fangping Zhao; Darell D Bigner; Roger E McLendon; Yuchen Jiao; Yiping He; Matthew S Waitkus; Hai Yan
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

6.  Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency.

Authors:  Chang Liu; Brian Duffy; Jeffrey J Bednarski; Cecelia Calhoun; Lindsay Lay; Barrett Rundblad; Jacqueline E Payton; Thalachallour Mohanakumar
Journal:  Am J Clin Pathol       Date:  2016-02-01       Impact factor: 2.493

7.  geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data.

Authors:  Matthias Döring; Joachim Büch; Georg Friedrich; Alejandro Pironti; Prabhav Kalaghatgi; Elena Knops; Eva Heger; Martin Obermeier; Martin Däumer; Alexander Thielen; Rolf Kaiser; Thomas Lengauer; Nico Pfeifer
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

8.  Delimiting Allelic Imbalance of TYMS by Allele-Specific Analysis.

Authors:  Emilia Balboa-Beltrán; Raquel Cruz; Angel Carracedo; Francisco Barros
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 9.  Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis.

Authors:  Rimma Berenstein
Journal:  Biomark Insights       Date:  2015-08-05

10.  Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing.

Authors:  Vinzenz Lange; Irina Böhme; Jan Hofmann; Kathrin Lang; Jürgen Sauter; Bianca Schöne; Patrick Paul; Viviane Albrecht; Johanna M Andreas; Daniel M Baier; Jochen Nething; Ulf Ehninger; Carmen Schwarzelt; Julia Pingel; Gerhard Ehninger; Alexander H Schmidt
Journal:  BMC Genomics       Date:  2014-01-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.